| Income Statement | 2025-09-30 | 2024-09-30 | ||
|---|---|---|---|---|
| Total net sales | 19,190,468 | 19,482,167 | ||
| Cost of sales | 7,222,213 | 7,486,626 | ||
| Gross profit | 11,968,255 | 11,995,541 | ||
| Operating expenses | 14,130,845 | 15,310,951 | ||
| Loss from operations | -2,162,590 | -3,315,410 | ||
| Decrease of contingent liability | 0 | -74,580 | ||
| Increase in fair value of convertible debt | 87,380 | -429,789 | ||
| Interest income (expense) | 34,308 | -29,507 | ||
| Loss before provision for income taxes | -2,040,902 | -3,700,126 | ||
| Benefit (expense) for income taxes | 0 | - | ||
| Net loss | -2,040,902 | -3,700,126 | ||
| Preferred dividends | 2,334,501 | 4,004,001 | ||
| Net loss attributable to common shareholders | -4,375,403 | -7,704,127 | ||
| Basic earnings per share (in dollars per share) | -1.09 | -1.79 | ||
| Shares used in computing basic earnings per share (in shares) | 4,022,629 | 4,312,546 | ||
| Us-gaap_earningspersharediluted | -1.09 | -1.79 | ||
| Us-gaap_weightedaveragenumberofdilutedsharesoutstanding | 4,022,629 | 4,312,546 | ||
cbdMD, Inc. (YCBD)
cbdMD, Inc. (YCBD)